The new funding helps Phlow accelerate its mission to help make ingredients for medicines either considered in short supply ...

Phlow’s capital raise announcement came a day after Gov. Glenn Youngkin and British pharmaceutical firm AstraZeneca publicly ...

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), and Antheia, the pharmaceutical ingredient manufacturer transforming essential medicine ...

Phlow Corp., a leading American pharmaceutical contract development and manufacturing organization (CDMO), today announced the successful close of its Series C financing ...

The arrangement will allow medicines to be built inside the United States from start to finish, Phlow's CEO said.

Richmond-based pharmaceutical manufacturing company Phlow announced Tuesday that it had secured $37 million in a capital raise.

“Phlow has embarked on a bold mission to provide access to affordable, high-quality essential medicines for every American,” said Eric Edwards, M.D., Ph.D., co-founder, president and CEO of Phlow.

From the Winter 2021/2022 issue of Inc. Magazine Eric Edwards, co-founder and CEO of Phlow. Photo: Courtesy company. Illustration: Inc. Magazine ...

Its new products rely on foreign supplies. Phlow Corp. won White House backing to revitalize domestic manufacturing of active pharmaceutical ingredients March 9, 2022 More than 3 years ago 7 min ...